AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 58 filers reported holding AGILE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $130,000 | +62.5% | 621,200 | +281.3% | 0.00% | – |
Q4 2021 | $80,000 | +128.6% | 162,900 | +341.6% | 0.00% | – |
Q3 2021 | $35,000 | -96.8% | 36,885 | -95.6% | 0.00% | -100.0% |
Q2 2021 | $1,111,000 | +39.2% | 835,559 | +117.8% | 0.00% | 0.0% |
Q1 2021 | $798,000 | +99.0% | 383,611 | +166.0% | 0.00% | – |
Q2 2020 | $401,000 | -78.3% | 144,221 | -85.5% | 0.00% | -100.0% |
Q1 2020 | $1,847,000 | -77.4% | 992,746 | -69.6% | 0.00% | -66.7% |
Q4 2019 | $8,164,000 | +183.9% | 3,265,601 | +34.5% | 0.01% | +200.0% |
Q3 2019 | $2,876,000 | -12.6% | 2,427,100 | +7.7% | 0.00% | -33.3% |
Q2 2019 | $3,291,000 | +2.1% | 2,254,180 | +5.6% | 0.00% | 0.0% |
Q1 2019 | $3,222,000 | +188.2% | 2,133,777 | +10.0% | 0.00% | +200.0% |
Q4 2018 | $1,118,000 | +149.0% | 1,940,677 | +58.6% | 0.00% | – |
Q3 2018 | $449,000 | -71.0% | 1,223,897 | -1.5% | 0.00% | -100.0% |
Q2 2018 | $1,548,000 | +33.9% | 1,242,690 | +176.3% | 0.00% | 0.0% |
Q1 2018 | $1,156,000 | +17.4% | 449,700 | +22.8% | 0.00% | 0.0% |
Q4 2017 | $985,000 | +149.4% | 366,100 | +313.7% | 0.00% | – |
Q3 2017 | $395,000 | +262.4% | 88,500 | +161.1% | 0.00% | – |
Q1 2017 | $109,000 | -70.1% | 33,900 | -47.0% | 0.00% | -100.0% |
Q4 2016 | $365,000 | +153.5% | 64,000 | +209.2% | 0.00% | – |
Q3 2016 | $144,000 | -63.1% | 20,700 | -54.4% | 0.00% | -100.0% |
Q2 2015 | $390,000 | +6.0% | 45,410 | +14.5% | 0.00% | 0.0% |
Q1 2015 | $368,000 | – | 39,664 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|